Zoledronic Acid J Code Description, Reimbursement, Modifiers & Guidelines

Zoledronic Acid J Code Description, Reimbursement, Modifiers & Guidelines

Zoledronic acid J code (HCPCS J3489) is applied for service when Zoledronic acid (1 mg) injects by the physician or other healthcare provider. Zoledronic acid administers to the patient to treat abnormal blood calcium levels caused by cancer and bone metastases from solid tumors. Zoledronic Acid J Code Description Zoledronic acid aids to decreased the…

(2022) CPT Code G0463 – Description, Guidelines,  Reimbursement, Modifiers & Examples

(2022) CPT Code G0463 – Description, Guidelines, Reimbursement, Modifiers & Examples

CPT code G0463 will be reported by the physician when service renders at the hospital outpatient clinic visit for assessment and management of a patient. Summary In 2014, CMS proposed three new HCPCS G codes in OPPS (Outpatient Prospective Payment System) to substitute for five levels of evaluation and management settings. It includes one G…

HCPCS G0402, G0438 & G0439 (Healthcare Common Procedure Coding System)

HCPCS G0402, G0438 & G0439 (Healthcare Common Procedure Coding System)

The HCPCS codes G0402, G0438 & G0439 are used for Healthcare Common Procedure Coding System and the descriptions of the codes can be found underneath. G0438 Description of G0438: First visit, annual wellness visit, includes a personalized prevention plan. G0439 Description of G0439: Subsequent visit, annual wellness visit, includes a personalized prevention plan. Note: G0438…

(2022) How To Code HCPCS Codes J3490 & J3590 – Descriptions & Guidelines

(2022) How To Code HCPCS Codes J3490 & J3590 – Descriptions & Guidelines

This article outlines the coding guidelines and descriptions of HCPCS Codes J3490 & J3590. HCPCS J3490 Description of J3490: Unclassified drug. HCPCS J3590 Description of J3590: Unclassified biologic. Billing Guidelines For HCPCS Codes J3490 & J3590 HCPCS J3490 (unclassified drug) and J3590 (unclassified biologic) are the HCPCS codes that are reported for medications that are…

Claims With HCPCS A9552 Reported For Oncologic Conditions

Claims With HCPCS A9552 Reported For Oncologic Conditions

Claims for Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) for solid tumors submitted between October 6 and November 30, 2014 will be held to ensure that Medicare systems can accurately calculate payments. Specifically, these are claims containing Healthcare Common Procedure Coding System (HCPCS) A9552 for all oncologic conditions. No provider action is required.

HCPCS G8553 And ERX Claims Updates

HCPCS G8553 And ERX Claims Updates

G8553 CPT that was used for eRx claims is no longer valid for claims billed dates of service 01/01/2014 and after.Individual eligible professionals and group practices participating in the eRx Group Practice Reporting Option (GPRO) who are not successful electronic prescribers will be subject to a 2.0% payment adjustment on their Medicare Part B services…